Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Chiroscience discloses new MMP/TNF inhibitors

Jan. 7, 1998

Anika files for U.S. approval of osteoarthritis Rx

Jan. 5, 1998

COX-2 inhibitors reported by UPSA

Jan. 5, 1998

VX-740 advances in preclinical studies

Jan. 2, 1998

UPSA claims new COX-2 inhibitors for inflammation, pain and other disorders

Dec. 31, 1997

FDA approves Arthrotec, a new arthritis medication with NSAID efficacy and improved GI safety

Dec. 30, 1997

New antiinflammatory compounds disclosed by Glycomed

Dec. 30, 1997

Alexion files IND for C5 inhibitor treatment for rheumatoid arthritis

Dec. 29, 1997

Phase IIb trial of TCR vaccine for rheumatoid arthritis begins

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026